Clinical Trial Update: Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine sedation as a potential neuroprotective treatment after out-of-hospital cardiac arrest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Out-of-hospital Cardiac Arrest

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Christian Hassager | Conditions: Out-of-hospital Cardiac Arrest (OHCA) | Phase 2 | Status: RECRUITING